摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(3,5-difluorophenyl)-2-hydroxy-1-phenylethanone | 607391-74-2

中文名称
——
中文别名
——
英文名称
2-(3,5-difluorophenyl)-2-hydroxy-1-phenylethanone
英文别名
3',5'-Difluorobenzoin
2-(3,5-difluorophenyl)-2-hydroxy-1-phenylethanone化学式
CAS
607391-74-2
化学式
C14H10F2O2
mdl
——
分子量
248.229
InChiKey
HVOMFRZRGBVXFL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    353.7±37.0 °C(Predicted)
  • 密度:
    1.317±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    18
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.07
  • 拓扑面积:
    37.3
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-(3,5-difluorophenyl)-2-hydroxy-1-phenylethanone硝酸铵 、 copper diacetate 、 溶剂黄146 作用下, 反应 2.5h, 以100%的产率得到1-(3,5-difluorophenyl)-2-phenylethane-1,2-dione
    参考文献:
    名称:
    [EN] HYDANTOINS THAT MODULATE BACE-MEDIATED APP PROCESSING
    [FR] HYDANTOÏNE MODULANT LE TRAITEMENT D'APP MÉDIÉ PAR BACE
    摘要:
    在某些实施例中,本文提供了一些有效抑制BACE对APP活性的咪唑烷酮化合物。在没有受限于特定理论的情况下,据信此处识别的咪唑烷酮的活性似乎与结合到BACE和/或APP有关,特别是当这些基团形成BACE/APP复合物时。因此,据信本文描述的化合物代表了一类新的化合物,被称为APP结合BACE抑制剂(ABBIs),并提供了一种新的机制来调节APP的加工。这里描述的咪唑烷酮似乎显示出改善的脑透过性和功能性BACE抑制作用。
    公开号:
    WO2014127042A1
  • 作为产物:
    参考文献:
    名称:
    [EN] HYDANTOINS THAT MODULATE BACE-MEDIATED APP PROCESSING
    [FR] HYDANTOÏNE MODULANT LE TRAITEMENT D'APP MÉDIÉ PAR BACE
    摘要:
    在某些实施例中,本文提供了一些有效抑制BACE对APP活性的咪唑烷酮化合物。在没有受限于特定理论的情况下,据信此处识别的咪唑烷酮的活性似乎与结合到BACE和/或APP有关,特别是当这些基团形成BACE/APP复合物时。因此,据信本文描述的化合物代表了一类新的化合物,被称为APP结合BACE抑制剂(ABBIs),并提供了一种新的机制来调节APP的加工。这里描述的咪唑烷酮似乎显示出改善的脑透过性和功能性BACE抑制作用。
    公开号:
    WO2014127042A1
点击查看最新优质反应信息

文献信息

  • HYDANTOINS THAT MODULATE BACE-MEDIATED APP PROCESSING
    申请人:Buck Institute for Research on Aging
    公开号:US20140371283A1
    公开(公告)日:2014-12-18
    In certain embodiments hydantoin compounds are provided herein that are effective to inhibit BACE activity against APP. Without being bound to a particular theory, it is believed the activity of the hydantoins identified herein appears to be associated with binding to BACE and/or to APP particularly when these moieties form a BACE/APP complex. Accordingly, it is believed the compounds described herein represent a new class of compounds designated herein as APP-Binding-BACE Inhibitors (ABBIs) and provide a new mechanism to modulate APP processing. The hydantoins described herein appear to show improved brain permeability and functional BACE inhibition.
    本文提供了某些咪唑二酮化合物,其有效抑制BACE对APP的活性。虽然没有受到特定理论的约束,但人们认为,在这里识别的咪唑二酮的活性似乎与其与BACE和/或APP结合有关,尤其是当这些基团形成BACE/APP复合物时。因此,认为本文所描述的化合物代表了一类新的化合物,被称为APP结合BACE抑制剂(ABBIs),并提供了一种调节APP加工的新机制。本文所描述的咪唑二酮似乎表现出改善的脑渗透性和功能性BACE抑制作用。
  • Hydantoins that modulate bace-mediated app processing
    申请人:Buck Institute for Research on Aging
    公开号:US10202355B2
    公开(公告)日:2019-02-12
    In certain embodiments hydantoin compounds are provided herein that are effective to inhibit BACE activity against APP. Without being bound to a particular theory, it is believed the activity of the hydantoins identified herein appears to be associated with binding to BACE and/or to APP particularly when these moieties form a BACE/APP complex. Accordingly, it is believed the compounds described herein represent a new class of compounds designated herein as APP-Binding-BACE Inhibitors (ABBIs) and provide a new mechanism to modulate APP processing. The hydantoins described herein appear to show improved brain permeability and functional BACE inhibition.
    在某些实施方案中,本文提供的海因化合物可有效抑制 BACE 对 APP 的活性。在不拘泥于特定理论的前提下,我们认为本文所确定的海因的活性似乎与 BACE 和/或 APP 的结合有关,特别是当这些分子形成 BACE/APP 复合物时。因此,我们认为本文所述的化合物代表了一类新的化合物,本文将其命名为 APP 结合-BACE 抑制剂 (ABBI),并提供了一种调节 APP 处理过程的新机制。本文所述的 hydantoins 似乎具有更好的脑渗透性和功能性 BACE 抑制作用。
  • Hydantoins that modulate BACE-mediated APP processing
    申请人:Buck Institute for Research on Aging
    公开号:US10766867B2
    公开(公告)日:2020-09-08
    In certain embodiments hydantoin compounds are provided herein that are effective to inhibit BACE activity against APP. Without being bound to a particular theory, it is believed the activity of the hydantoins identified herein appears to be associated with binding to BACE and/or to APP particularly when these moieties form a BACE/APP complex. Accordingly, it is believed the compounds described herein represent a new class of compounds designated herein as APP-Binding-BACE Inhibitors (ABBIs) and provide a new mechanism to modulate APP processing. The hydantoins described herein appear to show improved brain permeability and functional BACE inhibition.
    在某些实施方案中,本文提供的海因化合物可有效抑制 BACE 对 APP 的活性。在不拘泥于特定理论的前提下,我们认为本文所确定的海因的活性似乎与 BACE 和/或 APP 的结合有关,特别是当这些分子形成 BACE/APP 复合物时。因此,我们认为本文所述的化合物代表了一类新的化合物,本文将其命名为 APP 结合-BACE 抑制剂 (ABBI),并提供了一种调节 APP 处理过程的新机制。本文所述的 hydantoins 似乎具有更好的脑渗透性和功能性 BACE 抑制作用。
  • Hydantoins that modulate BACE-mediated app processing
    申请人:BUCK INSTITUTE FOR RESEARCH ON AGING
    公开号:US11091444B2
    公开(公告)日:2021-08-17
    In certain embodiments hydantoin compounds are provided herein that are effective to inhibit BACE activity against APP. Without being bound to a particular theory, it is believed the activity of the hydantoins identified herein appears to be associated with binding to BACE and/or to APP particularly when these moieties form a BACE/APP complex. Accordingly, it is believed the compounds described herein represent a new class of compounds designated herein as APP-Binding-BACE Inhibitors (ABBIs) and provide a new mechanism to modulate APP processing. The hydantoins described herein appear to show improved brain permeability and functional BACE inhibition.
    在某些实施方案中,本文提供的海因化合物可有效抑制 BACE 对 APP 的活性。在不拘泥于特定理论的前提下,我们认为本文所确定的海因的活性似乎与 BACE 和/或 APP 的结合有关,特别是当这些分子形成 BACE/APP 复合物时。因此,我们认为本文所述的化合物代表了一类新的化合物,本文将其命名为 APP 结合-BACE 抑制剂 (ABBI),并提供了一种调节 APP 处理过程的新机制。本文所述的 hydantoins 似乎具有更好的脑渗透性和功能性 BACE 抑制作用。
  • Photoremovable Protecting Groups for Phosphorylation of Chiral Alcohols. Asymmetric Synthesis of Phosphotriesters of (-)-3',5'-Dimethoxybenzoin
    作者:Michael C. Pirrung、Steven W. Shuey
    DOI:10.1021/jo00093a021
    日期:1994.7
    Procedures have been developed for the preparation of dimethoxybenzoinyl (DMB) phosphate triesters that can be deprotected photochemically. These compounds can be useful in light-directed synthesis and caging. The photochemistry of a wide variety of fluorine-, oxygen-, and nitrogen-substituted benzoin acetates was examined to determine the substitution pattern in the nonacylated aromatic ring producing optimum chemical yields. Two groups, 2',3'-dimethoxybenzoin and 3',5'dimethoxybenzoin, were found to give the highest yields of the benzofuran product and were further developed for the photochemical deprotection of phosphate esters. These reactions could not be quenched, suggesting a singlet photosolvolysis mechanism. An asymmetric synthesis of 3',5'dimethoxybenzoin via the benzaldehyde cyanohydrin was developed that minimizes the number of diastereomers formed in the phosphorylation of chiral alcohols. A phosphoramidite reagent for the derivatization of alcohols was prepared and used to produce scalemic dimethoxybenzoinyl phosphate esters from pantolactone and glycerol, serine, and tyrosine derivatives. These compounds were deprotected photochemically to produce the phosphodiesters in high yield.
查看更多

同类化合物

(E,Z)-他莫昔芬N-β-D-葡糖醛酸 (E/Z)-他莫昔芬-d5 (4S,5R)-4,5-二苯基-1,2,3-恶噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S,5R,5''R)-2,2''-(1-甲基亚乙基)双[4,5-二氢-4,5-二苯基恶唑] (4R,5S)-4,5-二苯基-1,2,3-恶噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4R,4''R,5S,5''S)-2,2''-(1-甲基亚乙基)双[4,5-二氢-4,5-二苯基恶唑] (1R,2R)-2-(二苯基膦基)-1,2-二苯基乙胺 鼓槌石斛素 黄子囊素 高黄绿酸 顺式白藜芦醇三甲醚 顺式白藜芦醇 顺式己烯雌酚 顺式-白藜芦醇3-O-beta-D-葡糖苷酸 顺式-桑皮苷A 顺式-曲札芪苷 顺式-二苯乙烯 顺式-beta-羟基他莫昔芬 顺式-a-羟基他莫昔芬 顺式-3,4',5-三甲氧基-3'-羟基二苯乙烯 顺式-1-(3-甲基-2-萘基)-2-(2-萘基)乙烯 顺式-1,2-双(三甲基硅氧基)-1,2-双(4-溴苯基)环丙烷 顺式-1,2-二苯基环丁烷 顺-均二苯乙烯硼酸二乙醇胺酯 顺-4-硝基二苯乙烯 顺-1-异丙基-2,3-二苯基氮丙啶 非洲李(PRUNUSAFRICANA)树皮提取物 阿非昔芬 阿里可拉唑 阿那曲唑二聚体 阿托伐他汀环氧四氢呋喃 阿托伐他汀环氧乙烷杂质 阿托伐他汀环(氟苯基)钠盐杂质 阿托伐他汀环(氟苯基)烯丙基酯 阿托伐他汀杂质D 阿托伐他汀杂质94 阿托伐他汀杂质7 阿托伐他汀杂质5 阿托伐他汀内酰胺钠盐杂质 阿托伐他汀中间体M4 阿奈库碘铵 锌(II)(苯甲醛)(四苯基卟啉) 银松素 铜酸盐(5-),[m-[2-[2-[1-[4-[2-[4-[[4-[[4-[2-[4-[4-[2-[2-(羧基-kO)苯基]二氮烯基-kN1]-4,5-二氢-3-甲基-5-(羰基-kO)-1H-吡唑-1-基]-2-硫代苯基]乙烯基]-3-硫代苯基]氨基]-6-(苯基氨基)-1,3,5-三嗪-2-基]氨基]-2-硫代苯基]乙烯基]-3-硫代 铒(III) 离子载体 I 铀,二(二苯基甲酮)四碘- 钾钠2,2'-[(E)-1,2-乙烯二基]二[5-({4-苯胺基-6-[(2-羟基乙基)氨基]-1,3,5-三嗪-2-基}氨基)苯磺酸酯](1:1:1) 钠{4-[氧代(苯基)乙酰基]苯基}甲烷磺酸酯 钠;[2-甲氧基-5-[2-(3,4,5-三甲氧基苯基)乙基]苯基]硫酸盐 钠4-氨基二苯乙烯-2-磺酸酯